PeterTessier
PhD
Location
Ann Arbor, MI, USA
Current Organization
University of Michigan
Biography
Peter Tessier is the Albert M. Mattocks (Endowed) Professor in the Departments of Chemical Engineering, Pharmaceutical Sciences and Biomedical Engineering, and a member of the Biointerfaces Institute and Chemical Biology Program at the University of Michigan in Ann Arbor, MI. He received his Ph.D. in Chemical Engineering from the University of Delaware (2003, NASA Graduate Fellow) and performed his postdoctoral studies at the Whitehead Institute for Biomedical Research at MIT (2003-2007, American Cancer Society Fellow). Tessier started his independent career as an assistant professor in the Department of Chemical & Biological Engineering at Rensselaer Polytechnic Institute in 2007, and he was an endowed full professor at Rensselaer prior to moving to the University of Michigan in 2017. His research focuses on designing, optimizing, characterizing, and formulating a class of large therapeutic proteins (antibodies) that hold great potential for detecting and treating human disorders ranging from cancer to neurodegenerative diseases. He has received several awards and fellowships in recognition of his pioneering work: Pew Scholar Award in Biomedical Sciences (2010-2014), Humboldt Fellowship for Experienced Researchers (2014-2015), Young Scientist Award from the World Economic Forum (2014), Young Investigator Award from the American Chemical Society (2015) and a CAREER Award from the National Science Foundation (2010-2015).
Grants
Grants Featuring
Peter Tessier, PhD
Alzheimer's Disease Research
Efficient Brain Delivery of Neuroprotective Antibodies
Active Dates
July 01, 2022 - December 30, 2024
Principal Investigator
Peter Tessier, PhD
Efficient Brain Delivery of Neuroprotective Antibodies
Active Dates
July 01, 2022 - December 30, 2024
Principal Investigator
Peter Tessier, PhD
Alzheimer's Disease Research
Peptide Imaging Agents Specific for Tau Aggregates
Active Dates
September 01, 2017 - August 31, 2021
Principal Investigator
Peter Tessier, PhD
Peptide Imaging Agents Specific for Tau Aggregates
Active Dates
September 01, 2017 - August 31, 2021
Principal Investigator
Peter Tessier, PhD
Alzheimer's Disease Research
Structure of Abeta C-Terminal Domain in Toxic Oligomers
Active Dates
July 01, 2011 - January 31, 2014
Principal Investigator
Peter Tessier, PhD
Structure of Abeta C-Terminal Domain in Toxic Oligomers
Active Dates
July 01, 2011 - January 31, 2014
Principal Investigator
Peter Tessier, PhD